Very high TAFI antigen levels are associated with a lower risk of hard coronary events: the PRIME Study

被引：32

作者：

Juan-Vague, I ^{[1
]}

Morange, PE ^{[1
]}

机构：

[1] CHU Timone, Hematol Lab, Dept Hematol, F-13385 Marseille 5, France

来源：

JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2003年 / 1卷 / 10期

关键词：

D O I：

10.1046/j.1538-7836.2003.00398.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2243 / 2244

页数：2

共 8 条

[1] Thrombin activatable fibrinolysis inhibitor and an antifibrinolytic pathway [J].

Bajzar, L .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (12) :2511-2518

[2] Plasma TAFI antigen variations in healthy subjects [J].

Chetaille, P ;

Alessi, MC ;

Kouassi, D ;

Morange, PE ;

Juhan-Vague, I .

THROMBOSIS AND HAEMOSTASIS, 2000, 83 (06) :902-905

[3] Five-year incidence of angina pectoris and other forms of coronary heart disease in healthy men aged 50-59 in France and Northern Ireland:: the Prospective Epidemiological Study of Myocardial Infarction (PRIME) Study [J].

Ducimetière, P ;

Ruidavets, JB ;

Montaye, M ;

Haas, B ;

Varnell, J .

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2001, 30 (05) :1057-1062

[4] Plasma thrombin-activatable fibrinolysis inhibitor antigen concentration and genotype in relation to myocardial infarction in the North and South of Europe [J].

Juhan-Vague, I ;

Morange, PE ;

Aubert, H ;

Henry, M ;

Aillaud, MF ;

Alessi, MC ;

Samnegård, A ;

Hawe, E ;

Yudkin, J ;

Margaglione, M ;

Di Minno, G ;

Hamsten, A ;

Humphries, SE .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (05) :867-873

[5] Association between TAFI antigen and Ala 147Thr polymorphism of the TAFI gene and the angina pectoris incidence - The PRIME Study [J].

Morange, PE ;

Juhan-Vague, I ;

Scarabin, PY ;

Alessi, MC ;

Luc, G ;

Arveiler, D ;

Ferrieres, J ;

Amouyel, P ;

Evans, A ;

Ducimetiere, P .

THROMBOSIS AND HAEMOSTASIS, 2003, 89 (03) :554-560

[6] Thrombin activatable fibrinolysis inhibitor (TAFI) levels in patients with coronary artery disease investigated by angiography [J].

Schroeder, V ;

Chatterjee, T ;

Mehta, H ;

Windecker, S ;

Pham, T ;

Devantay, N ;

Meier, B ;

Kohler, HP .

THROMBOSIS AND HAEMOSTASIS, 2002, 88 (06) :1020-1025

[7]

Silveira A, 2000, THROMB HAEMOSTASIS, V84, P364

[8] The PRIME study: classical risk factors do not explain the severalfold differences in risk of coronary heart disease between France and Northern Ireland [J].

Yarnell, JWG .

QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 1998, 91 (10) :667-676

← 1 →